Artificial intelligence may predict ovarian cancer recurrence — a large study puts it to the test
NCT ID NCT07721675
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study looks at whether artificial intelligence and detailed molecular analysis can help predict how high-grade serous ovarian cancer will behave after surgery. Researchers will analyze tumor images, genetic data, and patient records from 1,300 women to build a model that forecasts recurrence and survival. The goal is to better understand the tumor's immune environment and improve personalized care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a personalized AI tool that predicts ovarian cancer recurrence and guides treatment decisions.
- What could go wrong
- This is an observational study, not a treatment trial. The AI model may not be accurate enough for clinical use, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.